(19)
(11) EP 4 103 595 A1

(12)

(43) Date of publication:
21.12.2022 Bulletin 2022/51

(21) Application number: 21753290.2

(22) Date of filing: 10.02.2021
(51) International Patent Classification (IPC): 
C07K 14/705(2006.01)
G01N 33/574(2006.01)
G01N 33/53(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/805; G01N 2015/0076; G01N 33/80; G01N 33/82; G01N 33/6893; G01N 2800/22; G01N 2800/60; A61P 7/06; G01N 33/84
(86) International application number:
PCT/US2021/017481
(87) International publication number:
WO 2021/163209 (19.08.2021 Gazette 2021/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 11.02.2020 US 202062972835 P

(71) Applicant: Quest Diagnostics Investments LLC
Secaucus, NJ 07094 (US)

(72) Inventors:
  • SNYDER, Louis Michael
    Framingham, Massachusetts 01702 (US)
  • DLOTT, Jeffrey Samuel
    Reston, Virginia 20194 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) SYSTEM FOR DETERMINING AN UNDERLYING CAUSE OF ANEMIA